Navigation Links
Another fisheries commission throws the science overboard in tuna decision, WWF says
Date:12/12/2008

BUSAN, South Korea, December 12, 2008 The Western and Central Pacific Fisheries Commission (WCPFC) decision to make only minor reductions in fishing for bigeye and yellowfin tuna does nothing to help stop the demise of these species, World Wildlife Fund said today. The WCPFC disregarded the advice of its science committee and its chair in making this decision, which comes just a few weeks after the International Commission for the Conservation of Atlantic Tunas (ICCAT) and the Inter-American Tropical Tuna Commission (IATTC) also rejected their scientists' pleas for significant cuts to catches in the face of declining tuna populations.

"Commissions charged with protecting tuna populations are proving completely ineffective and inadequate," said Mark Stevens, senior program officer at World Wildlife Fund. "If they are willing to ignore the advice of their own scientists then we can have little faith in their ability to prevent the demise of this species."

Measures adopted by the WCPFC allow for a catch reduction of less than seven percent for bigeye and yellowfin tuna, according to WWF, which is well below the scientists' recommendation of an immediate 30 percent reduction.

Several additional measures to monitor these tuna fisheries were discarded or delayed.

Another tuna species, the bluefin tuna, is massively overfished to feed the worldwide sushi market. As bluefin populations dwindle, bigeye and yellowfin tuna stocks are put under intense pressure to compensate. "Disappearing, collapsing and declining bluefin tuna fisheries increase demand for bigeye and yellowfin tuna to supplement the high value sushi market," said Stevens. "What we are seeing now is an international tragedy where the failure of one fishery adds stress on others."

WCPFC's failures will also have severe impacts on local communities in Pacific island states, where foreign fishing fleets are impacting the availability of fish and threatening the
'/>"/>

Contact: Erika Viltz
erika.viltz@wwfus.org
202-778-9542
World Wildlife Fund
Source:Eurekalert

Page: 1 2

Related biology news :

1. Arctic ice on the verge of another all-time low
2. Viral recombination another way HIV fools the immune system
3. Ocean acidification -- another undesired side effect of fossil fuel-burning
4. For good or ill Ireland gains another mammal species
5. Another type of nanotube, a how-to guide to making bamboo-structured carbon nanotubes
6. Same gene protects from 1 disease, opens door to another
7. One species entire genome discovered inside anothers
8. A fisheries catch-22
9. Springer to publish Fisheries Science as of 2009
10. NC State takes research lead in protecting Puerto Ricos unique freshwater fisheries
11. New study offers solution to global fisheries collapse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Miami have analyzed images based on Synthetic Aperture ... Haiti,s earthquake, on January 12. The images reveal ... using data from Japan,s ALOS satellite and made ... of the European Space Agency (ESA) and GEO, ... of countries that promotes the exchange of satellite ...
(Date:2/9/2010)... People with anorexia nervosa, paradoxically, have strikingly high levels ... Children,s Hospital Boston. Their findings, based on MRI imaging ... 20 healthy girls of the same age, appear in ... and Mineral Research . , "It,s counter-intuitive that an ... be storing fat in her marrow," says endocrinologist Catherine ...
(Date:2/9/2010)... The Scripps Research Institute have discovered a potential new ... for sheep and cattle infected with liver fluke. The ... in combating river blindness, a tropical disease that is ... humans. , The study is scheduled for publication ... Proceedings of the National Academy of Sciences ...
Breaking Biology News(10 mins):New international satellite observations help assess future earthquake risk in Haiti 2Anorexics found to have excess fat-- in their bone marrow 2Scripps research team reveals how an old drug could have a new use for treating river blindness 2Scripps research team reveals how an old drug could have a new use for treating river blindness 3Scripps research team reveals how an old drug could have a new use for treating river blindness 4GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 1GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 2GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 3GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 4New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 1New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 2New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 3New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 4Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 1Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 2
... prevent global warming, researchers and policymakers are exploring a ... carbon dioxide that reaches the atmosphere. One possible approach ... the source an electric power plant, for example ... theoretically promising, the technique has never been tested in ...
... or array that can quickly detect disorders such as Down ... effective tool in prenatal diagnosis in a series of 300 ... report that appears in the current issue of the journal ... led by Dr. Arthur Beaudet and Dr. Sau Wai Cheung ...
... properties of cancer cells are their ability to divide without ... establish new tumor sites. Now, researchers from the Mayo ... acts as a deadly master switch, both freeing cancer cells ... is potentially good news, say the researchers, who published their ...
Other Biology News:MIT: Safe storage of greenhouse-gas carbon dioxide 2Microarray analysis improves prenatal diagnosis 2Microarray analysis improves prenatal diagnosis 3Mayo researchers identify dangerous 'two-faced' protein crucial to breast cancer spread and growth 2Mayo researchers identify dangerous 'two-faced' protein crucial to breast cancer spread and growth 3
(Date:2/9/2010)... endpoint Clinical ( www.endpointclinical.com ), a ... (IWR) systems, announced today that PULSE, a fully ... deploy clinical trial Integrated Response Technology (IRT) systems, ... clinical trials. This time and cost savings stems ... developers do not have to spend valuable time ...
(Date:2/9/2010)... A leading clinical research center in ... study an investigational drug designed as a possible treatment ... affects between 45 and 90 percent of women of ... not life threatening, dysmenorrhea can be debilitating and psychologically ... absenteeism from work and school. ,, Current therapies for ...
(Date:2/9/2010)... BEACH, California and AMSTERDAM , ... in molecular cancer diagnostics, announced today that,it has ... New York State ,Department of Health. The ... to receive,commercial samples of MammaPrint, its FDA-cleared breast ... this latest permit, Agendia has now obtained all ...
(Date:2/9/2010)... February 9 ,, ... Microplasmin to Improve the Treatment,of a Range of ... ThromboGenics NV (Euronext Brussels: THR), a ... innovative treatments for eye,disease, vascular disease and cancer, ... results, evaluating the product,s efficacy and,safety in patients ...
Breaking Biology Technology:endpoint Saves Money and Time for Medical Research Teams Through PULSE 2endpoint Saves Money and Time for Medical Research Teams Through PULSE 3Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps 2Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 3ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 4
... Training Center Scheduled to Open Friday, Feb. 29, ... Institute, LLC,will open its first training center in the ... local communities. Located in,Milipitas, CA, the center will be ... than 20 million Americans and costs the economy,$174 billion ...
... Continued year over year growth driven by Loestrin 24 ... Warner Chilcott,Limited (Nasdaq: WCRX ) today announced ... 2007. Revenue in the quarter ended December 31, 2007,totaled ... year quarter.,Revenue for the year ended December 31, 2007 ...
... today announced the submission of a supplemental New ... Administration (FDA) for once- daily,SEROQUEL XR(TM) (quetiapine fumarate) ... major depressive disorder (MDD) as,monotherapy, adjunct therapy, and ... 15 million American adults -- between 5 and ...
Other Biology Technology:MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care 2Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 2Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 3Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 4Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 5Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 6Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 7Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 8Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 9Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 10Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 11Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 12Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 13Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 14Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 15Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 16Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 17AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder 8
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Request Info...
Biology Products: